Analysts/Institutional Investor Meet/Con. Call Updates

October 29, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM Subject: Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference Call on October 29, 2026 at 2:00 P.M. Dear Sir/ Madam, In continuation to our earlier intimation dated October 21, 2026, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference Call held on October 29, 2026 at 2:00 P.M. for discussion of Q2 FY27 Unaudited Financial Results is available on the Company’s website at below link: https://www.jagsonpal.com/investor-relations/earning-calls/ The same is also uploaded on Company’s website. We request you to take the above on record. Thanking you, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance officer